Adherence to the Mediterranean lifestyle in patients after myocardial infarction

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
M Novakovic ◽  
J Tasic ◽  
B Krevel ◽  
U Rajkovic ◽  
M Bozic Mijovski ◽  
...  

Abstract Funding Acknowledgements Type of funding sources: None. OnBehalf ReKoBo study group INTRODUCTION Adherence to the Mediterranean diet is associated with decreased cardiovascular and overall mortality, and is recommended by the relevant preventive cardiology guidelines. However, besides specific dietary intake, Mediterranean lifestyle includes a series of eating habits and social behaviours. All these aspects are summed in the Medlife questionnaire. PURPOSE The aim of our study was to assess adherence to the Mediterranean lifestyle and examine associations with clinically relevant variables, in patients after myocardial infarction referred to cardiac rehabilitation. METHODS This was a single-centre cross-sectional study. Mediterranean lifestyle pattern was assessed using a validated Medlife questionnaire, which includes 28 questions (15 questions on the Mediterranean diet adherence, 6 questions on the eating habits and behaviour, and 7 questions on the social pattern of the Mediterranean lifestyle). Associations of the Medlife score with the exercise performance (assessed by the cardiopulmonary exercise testing), clinical data, demographics, lipid status, and quality of life (assessed by the HeartQol questionnaire) were assessed using Spearman’s correlation coefficient, while differences between two groups were determined with the independent-samples t-test. RESULTS There were 111 patients included in the study, mean age 55 +/- 10 years, 20% of them were women. Adherence to the Mediterranean lifestyle was not associated with age, BMI, peak VO2, total or LDL cholesterol. Also, there were no differences in terms of Medlife score between women vs. men, and between patients living in urban vs. rural areas. There were, however, significant associations between Medlife score and HDL (r = 0.239, p = 0.012), triglyceride level (r=-0.383, p < 0.001) and blood glucose level (r=-0.214, p = 0.024), and with the emotional aspects of the quality of life (r = 0.245, p = 0.017). Also, higher-educated were significantly more adherent to the Mediterranean lifestyle as compared to lower-educated patients (16.2 vs. 14.7 points, p = 0.018). CONCLUSION Poorer adherence to the Mediterranean lifestyle is associated with substandard control of lipid status and glucose level. Improvement in the Mediterranean lifestyle adherence might be a cornerstone in the cardiac rehabilitation beyond exercise training programmes.

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1932.2-1932
Author(s):  
K. El Aoufy ◽  
I. Antola ◽  
C. Sciortino ◽  
S. Bellando Randone ◽  
S. Guiducci ◽  
...  

Background:SSc is an autoimmune disease characterized by fibrosis of the skin and several internal organs involvement. The gastro intestinal tract is often affected causing a wide symptomatology that can involve the oesophagus, stomach and/or intestine.Objectives:To assess the gastro-intestinal tract with the UCLA SCTC GIT 2.0 questionnaire and the adherence to the Mediterranean diet with the Mediterranean Diet Score in a cohort of SSc patients.Methods:18 SSc patients classified with ACR/EULAR criteria (limited and diffuse subsets) were enrolled from January to April 2019, from the outpatient clinic of the University of Florence, Division of Rheumatology, Careggi Hospital. UCLA SCTC GIT 2.0 questionnaire for gastro-intestinal involvement (range 0-3), Mediterranean Diet Score (MDS range 0-14) for adherence to the Mediterranean diet, Health Assessment Questioning (range 0-3) for disability and SF-36 (range 0-100) for the quality of life were administered to patients. Data on weight and height were collected for the calculation of the Body Mass Index (BMI).Results:the18 SSc patients included had an average BMI of 23.9 ± 4.7 (M ± SD): only one patient was underweight (BMI=16.6) and 4 patients were overweight (BMI> 25).Our results show good adherence to the Mediterranean diet with a score of 9.78 ± 2.24 (M±SD) to the MDS. The quality of life assessed by SF-36 show scores were below the cut-off (<50), showing an impaired quality of general life (mental summary index = 36.32 ± 11.35 and physical summary index = 39.53 ± 8.61). Patients disability, assessed by HAQ, reports some difficulty in carrying out daily life activities due to the disease (0.52 ± 0.53- M ± SD).Gastro-intestinal involvement, measured with the UCLA GIT 2.0 questionnaire, shows moderate symptoms (0.50-1.00) in most items (reflux, abdominal distension, social function and emotional well-being), while a lower score (0.00-0.49) it was found in other items (diarrhea, constipation and faecal incontinence). Therefore, the total score of gastrointestinal involvement is moderate (0.42 ± 0.38 M ± SD).Conclusion:In SSc,Gastrointestinal involvement has a significant impact on quality of life, influencing the eating habits and sometimes leading to nutritional deficiencies. Further studies to analyse the eating habits of SSc patients are needed.References:[1]Wojteczek A, Dardzińska JA, Małgorzewicz S, Gruszecka A, Zdrojewski Z. Prevalence of malnutrition in systemic sclerosis patients assessed by different diagnostic tools.Clin Rheumatol. 2020 Jan;39(1):227-232. doi: 10.1007/s10067-019-04810-z. Epub 2019 Nov 16.[2]McMahan ZH Gastrointestinal involvement in systemic sclerosis: an update. Curr Opin Rheumatol. 2019 Nov;31(6):561-568. doi: 10.1097/BOR.0000000000000645.[3]Smith E, Pauling JD The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: A systematic literature review.Semin Arthritis Rheum. 2019 Aug;49(1):112-118. doi: 10.1016/j.semarthrit.2018.12.001. Epub 2018 Dec 6.Disclosure of Interests:Khadija El Aoufy: None declared, Irene Antola: None declared, Costanza Sciortino: None declared, Silvia Bellando Randone: None declared, Serena Guiducci: None declared, Daniel Furst Grant/research support from: AbbVie, Actelion, Amgen, BMS, Corbus Pharmaceuticals, the National Institutes of Health, Novartis, Pfizer, and Roche/Genentech, Consultant of: AbbVie, Actelion, Amgen, BMS, Cytori Therapeutics, Corbus Pharmaceuticals, the National Institutes of Health, Novartis, Pfizer, and Roche/Genentech, Speakers bureau: CMC Connect (McCann Health Company), Marco Matucci-Cerinic Grant/research support from: Actelion, MSD, Bristol-Myers Squibb, Speakers bureau: Acetelion, Lilly, Boehringer Ingelheim


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 700.2-700
Author(s):  
G. De Luca ◽  
G. Natalello ◽  
G. Abignano ◽  
C. Campochiaro ◽  
D. Temiz Karadağ ◽  
...  

Background:Gastrointestinal involvement(GI) is a common feature of systemic sclerosis(SSc) and can be highly disabling, representing a major cause of morbidity and reduced quality of life(QoL). The impact of dietary habits on GI symptoms, mood and QoL has not been extensively evaluated.Objectives:To evaluate the adherence to the Mediterranean Diet(MD) in an Italian multicenter cohort of SSc patients, and its impact on GI symptoms and other disease features, depression, anxiety and overall QoL.Methods:Consecutive SSc(ACR/EULAR2013) patients from 4 Italian cohorts were enrolled. Dietary habits and adherence to the MD were assessed using the 14-item MEDAS and QueMD questionnaires. Presence and severity of depressive/anxious symptoms and QoL were evaluated with the Hospital Anxiety and Depression Scale(HADS) and the SSc-HAQ(S-HAQ). GI symptoms were assessed with the Reflux Disease Questionnaire(RDQ) and the UCLA SCTC GI Tract 2.0 questionnaire(USG). Associations with patients’ lifestyle, disease characteristics, and nutritional status were explored.Results:265 patients (94.7% females; age 55.8±13.6years; disease duration 9.1±7.0years; diffuse SSc 31.8%; Scl70 + 35.8%;ulcers 23.4%;ILD 29.4%;BMI 23.7±4.4 Kg/m2; obese 11.3%,overweight 23.4%,underweight 4.9%) were enrolled.Overall MD adherence was moderate(7.5±1.9) according to MEDAS and it correlated with QueMD score(4.53±1.96)(R=.371,p<0.001). MD adherence was optimal in 39 patients(14.7%), more frequently from Central-Southern Italy(p=0.036); 189 patients(71.3%) had a good and 37(14.0%) a poor MD adherence.GI symptoms were moderate/severe according to USG in 37(14.0%) patients(USG:0.41±0.40), and heartburn was the most common GI symptom(35.2%). The prevalence of significant anxiety and depression was 24.1% and 17.0%.An inverse correlation was found between MD adherence and mood disturbances at HADS(MEDAS; R=-0.181,p=0.04), work impairment(QueMD;R=-0.247,p=0.005) and reduced QoL, both for GI (constipation at USG: R=-0.133,p=0.032) and general S-HAQ items(bowel:R=-0.181,p=0.04;severity R=-0.202,p=0.01;Raynaud:R=-0.217,p<0.001;ulcers: R=-0.207,p=0.01). MD adherence directly correlated with lung function(MEDAS;R=0.181,p=0.023 for FVC and R=0.170,p=0.03 for DLCO). Patients with MD optimal adherence had lower HADS depression(p=0.04) and S-HAQ scores(HAQ,p=0.04; Raynaud,p=0.005; ulcers,p=0.02) and lower work impairment and lost work time(p=0.03). No significant correlation emerged between MD adherence and BMI, or specific symptoms. Depression and anxiety directly correlated with the severity of reported upper GI symptoms according to both scales (RDQ-GERD:R=0.261,p=0.001; USG:R=0.263,p<0.001) and general S-HAQ items (HAQ: R=0.136,p=0.032;severity R=0.233,p<0.001;bowel: R=0.135,p=0.04;breath: R=0.133,p=0.03; ulcers: R=0.132,p=0.037). Results were confirmed after exclusion of psychiatric(11.7%) and fibromyalgic(15.5%) patients.Conclusion:Unsatisfactory MD adherence is associated with a low mood, impaired QoL, work impairment, GI and vascular symptoms in Italian SSc patients. The promotion of a healthy lifestyle could positively impact on QoL and disease status of SSc patients.References:[1]Gnagnarella P, et a. NMCD 2018. DOI: 10.1016/j.numecd.2018.06.006[2]Jaeger VK et al. PLoS One, 2016.[3]Dinu M et al. Eur J Clin Nutr 2018. doi: 10.1038/ejcn.2017.58.[4]Khanna D, et al.Arthritis Rheum. 2009. doi: 10.1002/art.24730.Acknowledgments:GILSDisclosure of Interests:Giacomo De Luca Grant/research support from: SOBI, Speakers bureau: SOBI, Novartis, Pfizer, MSD, Celgene, Gerlando Natalello: None declared, Giuseppina Abignano: None declared, Corrado Campochiaro Speakers bureau: Novartis, Pfizer, Roche, GSK, SOBI, Duygu Temiz Karadağ: None declared, Maria De Santis: None declared, Elisa Gremese Speakers bureau: Abbvie, BMS, Celgene, Jannsen, Lilly, MSD, Novartis, Pfizer, Sandoz, UCB, Silvia Laura Bosello Speakers bureau: Abbvie, Pfizer, Boehringer, Lorenzo Dagna Grant/research support from: Abbvie, BMS, Celgene, Janssen, MSD, Mundipharma Pharmaceuticals, Novartis, Pfizer, Roche, SG, SOBI, Consultant of: Abbvie, Amgen, Biogen, BMS, Celltrion, Novartis, Pfizer, Roche, SG, and SOBI


2007 ◽  
Vol 6 (3) ◽  
pp. 166-171 ◽  
Author(s):  
Jina Choo ◽  
Lora E. Burke ◽  
Kyung Pyo Hong

Background Health-related quality of life (HRQOL) has been used as a primary health outcome in cardiac rehabilitation programs (CRP). Aims This study aimed to evaluate the effects of an 8-week CRP on HRQOL and exercise capacity in myocardial infarction (MI) patients in Korea. Methods After matching on gender, age, and left ventricular ejection fraction, 60 subjects with a first acute MI were allocated to either a CRP group ( n =31) or a Control group ( n =29). The 8-week CRP included hospital-based, supervised exercise training (three times per week, average intensity of 65% VO2peak) and individual education sessions. The Control group was instructed on a home-based exercise regimen without contact during the 8 weeks. At baseline and 8 weeks, HRQOL was assessed by the Quality of Life Index (QLI)–cardiac version III; exercise capacity by a treadmill test. Results After adjusting for education level, the overall QLI, health/functioning and psycho/spiritual scores showed greater increases in the CRP group than the Control group ( p=.014, p=.016, and p=.036, respectively). We observed significant improvements in VO2peak ( p<.0001), anaerobic threshold ( p<.0001), and maximal exercise duration ( p<.0001) in the CRP group, compared to the Control group. Conclusions These findings suggest that the Korean CRP can lead to significant improvements in HRQOL outcomes and exercise capacity.


2021 ◽  
Vol 8 (12) ◽  
pp. 166
Author(s):  
María Mansilla-Chacón ◽  
José L. Gómez-Urquiza ◽  
María Begoña Martos-Cabrera ◽  
Luis Albendín-García ◽  
José L. Romero-Béjar ◽  
...  

Coronary heart disease is the leading cause of death and disability worldwide. Traditionally, cardiac rehabilitation programmes are offered after cardiac events to aid recovery, improve quality of life, and reduce adverse events. The objective of this review was to assess the health-related quality of life, after a supervised cardiac rehabilitation programme, of patients who suffered a myocardial infarction. A systematic review was carried out in the CINAHL, Cochrane, LILACS, Medline, Scopus, and SciELO databases, according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. Randomised controlled trials were selected. Meta-analyses were performed for the Short Form Health Survey SF-36, Myocardial Infarction Dimensional Assessment Scale (MIDAS), MacNew Heart Disease-Health-Related Quality of Life (HRQL) questionnaire, and European Quality of Life-Visual Analogue Scale (EuroQol-VAS) with the software Cochrane RevMan Web. Ten articles were found covering a total of 3577 patients. In the meta-analysis, the effect size of the cardiac rehabilitation programme was statistically significant in the intervention group for physical activity, emotional reaction, and dependency dimensions of the MIDAS questionnaire. For the control group, the score improved for SF-36 physical functioning, and body pain dimensions. The mean difference between the control and intervention group was not significant for the remaining dimensions, and neither for the MacNew Heart Disease-HRQL and EuroQol-VAS questionnaires. Supervised cardiac rehabilitation programmes were effective in improving health-related quality of life, however, there was a potential variability in the interventions; therefore, the results should be interpreted with caution. This study supports the importance of providing care and evaluating interventions via the supervision of trained health professionals, and further randomised clinical trials are needed to analyse the positive changes in mental and physical health outcomes.


2011 ◽  
Vol 66 (3) ◽  
pp. 360-368 ◽  
Author(s):  
P Henríquez Sánchez ◽  
C Ruano ◽  
J de Irala ◽  
M Ruiz-Canela ◽  
M A Martínez-González ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document